We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
+26.83%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$39.1M
AUM Growth
-$14M
Cap. Flow
-$11.7M
Cap. Flow %
-29.95%
Top 10 Hldgs %
95.65%
Holding
22
New
5
Increased
2
Reduced
1
Closed
5

Top Buys

Rank Stock Value
1
CMPX icon
Compass Therapeutics
CMPX
+$842K
2
CABA icon
Cabaletta Bio
CABA
+$308K
3
ALLK
Allakos
ALLK
+$127K
4
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$124K
5
NAMSW icon
NewAmsterdam Pharma Warrant
NAMSW
+$17.6K

Top Sells

Rank Stock Value
1
ACLX
Arcellx
ACLX
+$915K
2
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$880K
3
FLACW
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
+$17K
4
LUXAW
Lux Health Tech Acquisition Corp. Warrants
LUXAW
+$9K
5
PV.WS
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
+$2K

Sector Composition

Rank Sector Weight
1 Healthcare 75.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SVRA icon
1
Savara
SVRA
$1.13B
$10.7M 27.3%
6,896,551
– –
XERS icon
2
Xeris Biopharma Holdings
XERS
$1.5B
$8.03M 20.52%
6,039,028
– –
SPY icon
3
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$6.1M 15.58%
15,947
– –
RZLT icon
4
Rezolute
RZLT
$421M
$2.9M 7.42%
1,403,157
– –
SCYX icon
5
SCYNEXIS
SCYX
$44.5M
$2.69M 6.87%
215,493
– –
XOP icon
6
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.48B
$2.38M 6.07%
17,500
– –
VECT
7
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$1.35M 3.44%
156,222
+15,359
+11% +$124K
ACLX
8
DELISTED
Arcellx
ACLX
$1.12M 2.87%
36,302
-39,884
-52% -$915K
AMLP icon
9
Alerian MLP ETF
AMLP
$12.7B
$1.12M 2.87%
29,500
– –
CMPX icon
10
Compass Therapeutics
CMPX
$378M
$1.06M 2.71%
+211,159
New +$842K
CABA icon
11
Cabaletta Bio
CABA
$435M
$784K 2%
+84,728
New +$308K
MTEM
12
DELISTED
Molecular Templates, Inc.
MTEM
$673K 1.72%
136,866
– –
ALLK
13
DELISTED
Allakos
ALLK
$154K 0.39%
+18,271
New +$127K
ELEV
14
DELISTED
Elevation Oncology
ELEV
$64.8K 0.17%
68,324
+27
+0% +$27
NAMSW icon
15
NewAmsterdam Pharma Warrant
NAMSW
$17.8K 0.05%
+21,333
New +$17.6K
BTWNW
16
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$4.67K 0.01%
39,773
– –
LANV.WS
17
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$3.78K 0.01%
+12,000
New +$3.15K
USO icon
18
CALL
United States Oil Fund
USO
$2.54B
– –
-173,500
Closed -$11.3M
EIGR
19
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-3,896
Closed -$880K
PV.WS
20
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
– –
-12,000
Closed -$2K
FLACW
21
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
– –
-21,333
Closed -$17K
LUXAW
22
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
– –
-66,666
Closed -$9K

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q4 2022 Portfolio in Review

As of Q4 2022, Caxton Corporation held 22 positions worth $39.1M, down 26% from $53.2M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Caxton Corporation withdrew a net $11.7M in Q4 2022, closing 5 positions and reducing 1 holding. Its most notable exit was Eiger BioPharmaceuticals, Inc., an estimated $880K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 62% a quarter earlier.

Against the trend, Caxton Corporation opened a new position in Compass Therapeutics worth $1.06M.

  • Caxton Corporation's largest Q4 2022 buy was Compass Therapeutics: 211,159 shares worth $1.06M.
  • Caxton Corporation added most to VectivBio Holding AG Ordinary Shares in Q4 2022, an estimated $124K increase.
  • Caxton Corporation's biggest Q4 2022 reduction was Arcellx, cutting an estimated $915K.
  • Caxton Corporation fully exited Eiger BioPharmaceuticals, Inc. in Q4 2022, selling an estimated $880K.
  • Caxton Corporation's ten largest holdings make up 96% of its $39.1M portfolio in Q4 2022.
  • Caxton Corporation opened 5 new positions and closed 5 in Q4 2022.
  • Caxton Corporation's portfolio value fell 26% quarter-over-quarter to $39.1M.

Based on Caxton Corporation's 13F filing for Q4 2022, filed 14 Feb 2023.